Heidelberg Pharma AG

Director's Dealing • Feb 6, 2012

News Details

Directors’ Dealings | 6 February 2012 16:05

DGAP-DD: WILEX AG english

Notification concerning transactions by persons performing managerial responsibilities pursuant to section 15a of the WpHG Directors’ Dealings notification transmitted by DGAP – a company of EquityStory AG. The person with duty of notification is solely responsible for the content of this announcement. ————————————————————————— Details of the person subject to the disclosure requirement Company: dievini Hopp BioTech holding GmbH & Co. KG Person performing managerial responsibilities, triggering the disclosure requirement for the legal person Details of the person performing managerial responsibilities Position: Member of an administrative or supervisory body Information about the transaction with duty of notification Description of the financial instrument: Bearer shares of common stock ISIN/WKN of the financial instrument: DE0006614720 Type of transaction: Subscription Date: 01.02.2012 Price: 3.10 Currency: EUR No. of items: 975997 Total amount traded: 3025590.70 Place: Ausserbörslich / OTC Explanation for publication: dievini Hopp BioTech holding GmbH & Co. KG’s subscription of the new shares (subscription rights) from the rights issue is attributed to both corporate bodies, Prof. Dr. Friedrich von Bohlen und Halbach und Prof. Dr. Christof Hettich. Information about the company with duty of publication Issuer: WILEX AG Grillparzerstr. 10 81675 München Deutschland ISIN: DE0006614720 WKN: 661472 End of Directors’ Dealings Notification (c) DGAP 06.02.2012 DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de ID 14802